Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Long Term Provisions

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Long Term Provisions History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Long Term Provisions ₹155 Cr₹123 Cr₹98 Cr₹80 Cr₹72 Cr

What is the latest Long Term Provisions ratio of MANKIND PHARMA ?

The latest Long Term Provisions ratio of MANKIND PHARMA is ₹155 Cr based on Mar2025 Consolidated results.
Year Long Term Provisions
Mar2025₹155 Cr
Mar2024₹123 Cr
Mar2023₹98 Cr
Mar2022₹80 Cr
Mar2021₹72 Cr

How is Long Term Provisions of MANKIND PHARMA Trending?

Years Long Term Provisions % Change
Mar2025 ₹155 Cr
25.94
Mar2024 ₹123 Cr
25.78
Mar2023 ₹98 Cr
22.36
Mar2022 ₹80 Cr
10.74
Mar2021 ₹72 Cr -

Compare Long Term Provisions of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,147.4 Cr -4.9% -2.6% 6.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,594.0 Cr -3.3% -6.9% -9.7% Stock Analytics
DIVIS LABORATORIES ₹162,722.0 Cr 1.7% -6.8% 25.4% Stock Analytics
CIPLA ₹127,508.0 Cr -0.9% 0.5% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,111.0 Cr -1.9% -1.3% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,225.0 Cr -1.2% -2% -9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4.9%

-2.6%

6.1%

SENSEX

-2.2%

-1.7%

-1.2%


You may also like the below Video Courses